Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers
暂无分享,去创建一个
D. Park | Kyungbin Kim | Jeong Hee Lee | J. Kim | C. Lee | M. Sol | K. Choi | W. Park | D. Shin
[1] K. Jung,et al. Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010 , 2013, Cancer research and treatment : official journal of Korean Cancer Association.
[2] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[3] H. Moch,et al. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer , 2011, Virchows Archiv.
[4] Sohee Park,et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008 , 2011, Cancer research and treatment : official journal of Korean Cancer Association.
[5] G. Song,et al. Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.
[6] M. Lerman,et al. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? , 2009, Biochimica et biophysica acta.
[7] I. Ishiwata,et al. Therapeutic strategy targeting the mTOR–HIF‐1α–VEGF pathway in ovarian clear cell adenocarcinoma , 2009, Pathology international.
[8] A. Al-Attar,et al. Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies? , 2008, Clinical Cancer Research.
[9] A. Mobasheri,et al. Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics , 2007, Chemotherapy.
[10] C. Dang,et al. Effects of hypoxia on tumor metabolism , 2007, Cancer and Metastasis Reviews.
[11] G. Semenza,et al. Up‐regulation of gene expression by hypoxia is mediated predominantly by hypoxia‐inducible factor 1 (HIF‐1) , 2005, The Journal of pathology.
[12] K. Blackwell,et al. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? , 2004, The oncologist.
[13] A. Giaccia,et al. Hypoxic gene expression and metastasis , 2004, Cancer and Metastasis Reviews.
[14] F. Peale,et al. Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumours , 2004, Journal of Clinical Pathology.
[15] W. Murdoch,et al. Roles of the ovarian surface epithelium in ovulation and carcinogenesis. , 2002, Reproduction.
[16] A. Harris,et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.
[17] A. Harris,et al. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. , 2001, Anticancer research.
[18] R. Angioli,et al. GLUT‐1 expression in ovarian carcinoma , 2001, Cancer.
[19] A. Harris,et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.
[20] W. Sly,et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.
[21] Y. Sugisaki,et al. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma , 2000, British Journal of Cancer.
[22] G. Semenza. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.
[23] G. Semenza,et al. Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression , 2000, Critical reviews in biochemistry and molecular biology.
[24] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[25] F. Ismail-Beigi,et al. Dual Control of glut1 Glucose Transporter Gene Expression by Hypoxia and by Inhibition of Oxidative Phosphorylation* , 1997, The Journal of Biological Chemistry.
[26] G. Semenza,et al. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.
[27] M. Shimizu,et al. Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. , 2008, Oncology reports.
[28] Napoleone Ferrara,et al. The role of vascular endothelial growth factor in pathological angiogenesis , 2004, Breast Cancer Research and Treatment.
[29] S. Silverberg. Histopathologic grading of ovarian carcinoma: a review and proposal. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[30] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.